Literature DB >> 14624774

Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy.

B Kuru1, M Camlibel, S Dinc, M A Gulcelik, H Alagol.   

Abstract

AIMS: The American Joint Committee on Cancer staging system for breast carcinomas has been revised. According to this revised staging system, metastasis to infraclavicular lymph nodes and number of positive axillary nodes have prognostic significance and a new stage, stage IIIC, has been introduced. The aim of this study is to investigate the association of positive axillary nodes by level and number with survival and stage migration between the old and the new stages in a large series of mastectomy patients.
METHODS: Data from 1277 consecutive breast cancer patients treated by mastectomy were studied, retrospectively. Prognostic value of number of positive axillary nodes and entirely invasion of apex axillary nodes were analysed. Survival curves were generated by Kaplan-Meier method, and multivariate analysis was performed by Cox proportional hazard model.
RESULTS: Five-year survival rates for metastasis to axillary level III and for stage IIIC breast cancer were 35.4 and 38.2%, respectively. Metastases to apex axillary nodes, 4-9 and 10 or more positive lymph nodes were found to be adverse and independent prognostic factors for survival in lymph node positive patients.
CONCLUSION: Invasion of infraclavicular nodes and 4-9 and > or =10 positive axillary lymph nodes were independent predictors for survival in node positive breast carcinomas in this series. Patients with the new stage IIIC had the worst survival among breast cancer patients.

Entities:  

Mesh:

Year:  2003        PMID: 14624774     DOI: 10.1016/j.ejso.2003.08.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

Review 1.  Should FDG PET/CT be used for the initial staging of breast cancer?

Authors:  David Groheux; Elif Hindié; Domenico Rubello; Marc Espié; Georges Baillet; Sylvie Giacchetti; Jean-Louis Misset; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

Authors:  Dimitri Bellevre; Cécile Blanc Fournier; Odile Switsers; Audrey Emmanuelle Dugué; Christelle Levy; Djelila Allouache; Cédric Desmonts; Hubert Crouet; Jean-Marc Guilloit; Jean-Michel Grellard; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

3.  Metastatic axillary node ratio predicts recurrence and poor long-term prognosis in patients with advanced stage IIIC (pN3) breast cancer.

Authors:  Min Hee Hur; SeungSang Ko
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

4.  Merits of Level III Axillary Dissection in Node-Positive Breast Cancer: A Prospective, Single-Institution Study From India.

Authors:  Shalaka Joshi; Jarin Noronha; Rohini Hawaldar; Girish Kundgulwar; Vaibhav Vanmali; Vani Parmar; Nita Nair; Tanuja Shet; Rajendra Badwe
Journal:  J Glob Oncol       Date:  2019-02

5.  The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio.

Authors:  Yanxia Li; Earle Holmes; Karan Shah; Kevin Albuquerque; Anna Szpaderska; Cağatay Erşahin
Journal:  Patholog Res Int       Date:  2012-10-04

6.  Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer.

Authors:  Bengul Gunalp; Semra Ince; Alper Ozgur Karacalioglu; Asli Ayan; Ozdes Emer; Engin Alagoz
Journal:  Exp Ther Med       Date:  2012-08-09       Impact factor: 2.447

7.  Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer.

Authors:  Yun Yeong Kim; Heung Kyu Park; Kyung Hee Lee; Kwan Il Kim; Yong Soon Chun
Journal:  J Breast Cancer       Date:  2016-06-24       Impact factor: 3.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.